IFNA1 and lymphoma: Despite IFN-DC have been proved effective in generating T cell responses against solid tumors and lymphomas, the full potential of this immunotherapeutic strategy will be exploited in combination therapies, in order to generate tumor-specific immune responses associated with long-term survival.